I think this company makes gradual changes that doesn’t overwhelm their capacity to produce with gradual increases in revenue. As long as the revenues and the profits increase each time, that is growth. I used to chart companies with a 15% annual growth. If we could achieve anything near that, one day analyst will notice and this stock will achieve good value. I would rather see controlled growth and acquisition without undo pressure or dilution than some big announcement that doesn’t materialize. If they keep getting big clients like Walmart and there’s a move to produce drugs in the US, this pps will take off one day. JMHO
Market Data 
Markets 
AI
